Loading company…
Protalex, founded in 1999, develops biologic drugs for autoimmune diseases.
Founded in 1999 and headquartered in Florham Park, US, Protalex develops biologic drugs aimed at autoimmune diseases. John Doherty is listed as the founder. The company raised USD 15.20 mn in a PIPE round from investors including Bluebee Software, Emerging Technology Partners and Signal Peak Ventures. In 2018 it reported no revenue and EBITDA of USD -4,348,492. The listed stage is Public.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in